Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I ROBERTSON

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
European Heart Journal|June 1, 1988
Cardiac failure, the kidney, renin and atrial peptidesJ I Robertson, A M Richards
Journal of Cardiovascular Pharmacology|January 1, 1987
Converting enzyme inhibitors in the treatment of hypertensionJ I Robertson, D M Tillman
Cardiovascular Drugs and Therapy|June 1, 1991
Newer beta blockers and the treatment of hypertensionD McAreavey, R Vermeulen, J I Robertson
Clinical Science (London, England : 1979)|September 1, 1982
Exchangeable sodium in rats with Goldblatt two-kidney one-clip hypertensionD McAreavey, W B Brown, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1984
Exchangeable sodium measured serially in DOC-salt, post-DOC-salt, and Goldblatt hypertension in the ratD McAreavey, W B Brown, J I Robertson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1988
Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedyG D Murray, E Lesaffre, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1985
Ketanserin and alpha 1-adrenergic antagonism in humansJ R Zabludowski, S G Ball, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1987
Antihypertensive mode of action of ketanserinJ I Robertson, D J Stott, S G Ball
Lancet (London, England)|June 5, 1976
Pathogenesis of essential hypertensionJ J Brown, A F Lever, J I Robertson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Specificity of the serotonergic antagonist ketanserinD J Stott, J I Robertson, S G Ball
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
European Heart Journal|June 1, 1988
Cardiac failure, the kidney, renin and atrial peptidesJ I Robertson, A M Richards
Journal of Cardiovascular Pharmacology|January 1, 1987
Converting enzyme inhibitors in the treatment of hypertensionJ I Robertson, D M Tillman
Cardiovascular Drugs and Therapy|June 1, 1991
Newer beta blockers and the treatment of hypertensionD McAreavey, R Vermeulen, J I Robertson
Clinical Science (London, England : 1979)|September 1, 1982
Exchangeable sodium in rats with Goldblatt two-kidney one-clip hypertensionD McAreavey, W B Brown, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1984
Exchangeable sodium measured serially in DOC-salt, post-DOC-salt, and Goldblatt hypertension in the ratD McAreavey, W B Brown, J I Robertson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1988
Interpreting age-related aspects of antihypertensive treatment: statistical defects and their remedyG D Murray, E Lesaffre, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1985
Ketanserin and alpha 1-adrenergic antagonism in humansJ R Zabludowski, S G Ball, J I Robertson
Journal of Cardiovascular Pharmacology|January 1, 1987
Antihypertensive mode of action of ketanserinJ I Robertson, D J Stott, S G Ball
Lancet (London, England)|June 5, 1976
Pathogenesis of essential hypertensionJ J Brown, A F Lever, J I Robertson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Specificity of the serotonergic antagonist ketanserinD J Stott, J I Robertson, S G Ball
Pageof 18